News
GSK showcases positive data with lung cancer drugs at WCLC
New data at WCLC26 could push GSK's ROS1+ NSCLC drug Jideytro into the first-line setting, while B7-H3-targeted ADC ris-rez extends survival in SCLC.
R&D
Changing Faces: Pharma and biotech hires, August 2026
August brought another wave of leadership changes across biotech, pharma, and research organisations.
News
AZ's Etcamah falls short in first-line breast cancer trial
A week after getting FDA approval for frontline breast cancer treatment, AstraZeneca's Etcamah missed the mark in a trial aiming to expand its label.
R&D
Trial complexity is the new normal
When operationalised effectively, RBQM can support earlier risk detection and more targeted quality improvement.
News
Andy Plump to step down as Takeda's R&D chief
Andy Plump, credited with a 'soup-to-nuts' overhaul of Takeda's R&D in more than a decade of leadership at the division, has announced his retirement.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
